Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH) announced that three of its products, manufactured by its subsidiary Shanghai Zhonghua Pharmaceutical Co., Ltd., have received product licenses from Natural and Non-prescription Health Products Directorate (NNHPD) of Health Canada. The approved products include Longhu Qingliangyou Regular, Longhu Qingliangyou Ultra, and Longhu Gunzhu Fengyoujing Oil.

These three products are primarily indicated for the temporary relief of muscle and joint aches or discomfort. Shanghai Zhonghua Pharmaceutical Co., Ltd. submitted the product registration application to Natural and Non-prescription Health Products Directorate (NNHPD) of Health Canada in May 2026. As of the date of this announcement, the company has incurred registration costs of approximately RMB 49,500 for the marketing of these products in Canada.